HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.

AbstractOBJECTIVES:
Few studies have examined thrombosis in systemic lupus erythematosus (SLE), none have included Asian-Americans, and most have had small sample sizes. We analysed risk factors for thrombosis in a large, multi-ethnic SLE cohort.
METHODS:
We studied 1930 SLE subjects, including Caucasians, African-Americans, Asian-Americans and Hispanics. Data were derived from questionnaires and medical records. Documented history of thrombosis was the primary outcome. Explanatory variables included age at SLE diagnosis, gender, ethnicity, disease duration, smoking, antiphospholipid antibody (aPL) status, nephritis and specific medications.
RESULTS:
Smoking (OR 1.26, p = 0.011), longer disease duration (OR 1.26 per 5 years p = 0.027 x 10(-7)), nephritis (OR 1.35, p = 0.036), aPL positivity (OR 3.22, p<10(-9)) and immunomodulating medication use (OR 1.40, p = 0.011) were statistically significant risk factors for thrombosis. Younger age at SLE onset was protective (OR 0.52 for age </=20, p = 0.001). After adjusting for disease severity and incorporating propensity scores, hydroxychloroquine use remained significantly protective for thrombosis (OR 0.62, p = 4.91 x 10(-4)).
CONCLUSIONS:
This study confirms that older age at onset, longer disease duration, smoking, aPL positivity, history of nephritis and immunomodulating medication use are risk factors for thrombosis in SLE. These data are the first to confirm in a large and ethnically diverse SLE cohort that hydroxychloroquine use is protective for thrombosis.
AuthorsR Kaiser, C M Cleveland, L A Criswell
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 68 Issue 2 Pg. 238-41 (Feb 2009) ISSN: 1468-2060 [Electronic] England
PMID18782792 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Hydroxychloroquine
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • California (epidemiology)
  • Child
  • Female
  • Humans
  • Hydroxychloroquine (therapeutic use)
  • Immunosuppressive Agents (adverse effects)
  • Lupus Erythematosus, Systemic (complications, ethnology)
  • Lupus Nephritis (complications, ethnology)
  • Male
  • Middle Aged
  • Risk Factors
  • Sex Factors
  • Smoking (adverse effects, epidemiology)
  • Thrombosis (ethnology, etiology, prevention & control)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: